Role of plasmapheresis in thrombocytopenic purpura associated with waldenström's macroglobulinemia

Tushar C. Patel, S. Breanndan Moore

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


A 67-year-old man with Waldenström's macroglobulinemia had a relapse of chronic idiopathic thrombocytopenic purpura (ITP), which had been refractory to corticosteroids, splenectomy, vinca alkaloids, and high-dose intravenous γ-globulin therapy. A biclonal gammopathy (IgM K and IgG γ) was detected in his serum and was likely responsible for his refractory thrombocytopenia. He was treated with chlorambucil and prednisone. Plasmapheresis was effective in temporarily maintaining platelet counts and in decreasing morbidity until immunosuppression was completely effective against the production of the monoclonal protein. The previously reported experiences with use of plasmapheresis in patients with chronic ITP are discussed. Plasmapheresis may be of value in the treatment of selected patients with severe ITP and monoclonal gammopathy.

Original languageEnglish (US)
Pages (from-to)597-600
Number of pages4
JournalMayo Clinic proceedings
Issue number6
StatePublished - 1996

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Role of plasmapheresis in thrombocytopenic purpura associated with waldenström's macroglobulinemia'. Together they form a unique fingerprint.

Cite this